Related Experiment Videos
Low frequency maintenance ganciclovir for cytomegalovirus retinitis
A J Hall1, I D Jennens, C R Lucas
1University of Melbourne, Department of Ophthalmology, Victoria, Australia.
Scandinavian Journal of Infectious Diseases
|January 1, 1991
Abstract:
45 patients on maintenance ganciclovir for treated cytomegalovirus (CMV) retinitis were reviewed retrospectively. Treatment was given at 30 mg/kg/week in 3 divided doses: Monday, Wednesday, Friday. The median time to clinical relapse was 5.4 months. This is similar to that reported with higher frequency maintenance regimens. The high degree of immunodeficiency (median CD4 count 16 cells/microliters) and poor prognosis (median survival 8.2 months) associated with CMV retinitis were confirmed.